Načítá se...
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
BACKGROUND: SARS-CoV-2 is a novel coronavirus first recognized in late December 2019 that causes coronavirus disease 19 (COVID-19). Due to the highly contagious nature of SARS-CoV-2, it has developed into a global pandemic in just a few months. Antibody testing is an effective method to supplement t...
Uloženo v:
| Vydáno v: | BMC Immunol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7887538/ https://ncbi.nlm.nih.gov/pubmed/33596826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12865-021-00404-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|